See every side of every news story
Published loading...Updated

Monoacyl phospholipids to replace polysorbates as interfacial stabilizers in parenteral monoclonal antibody formulations - Pharma Excipients

Abstract Protein-based drugs are prone to both physical and chemical instability in aqueous solutions. Surfactants, such as polysorbates (PS), are commonly employed to mitigate interfacial stress, thus preventing protein aggregation and particle formation. However, polysorbates can undergo enzymatic hydrolysis by residual host cell proteins and oxidation during long-term storage in parenteral formulations. This can lead to the generation of fre…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharma Excipients broke the news in on Tuesday, July 29, 2025.
Sources are mostly out of (0)